Dioxin-induced fetal growth retardation: the role of a preceding attenuation in the circulating level of glucocorticoid

Endocrine

Volumn 47, Issue 2, 2014, Pages 572-580

  Hattori, Yukiko ^a   Takeda, Tomoki ^a   Fujii, Misaki ^a   Taura, Junki ^a   Ishii, Yuji ^a   Yamada, Hideyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

2,3,7,8 Tetrachlorodibenzo p dioxin (TCDD); Corticosterone; Fetus; Growth hormone; Growth retardation; Rat

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CORTICOSTERONE; CORTICOTROPIN; CYTOCHROME P450 1A2; CYTOCHROME P450 3A1; GLUCOCORTICOID; GLUCURONOSYLTRANSFERASE 1A6; GLUCURONOSYLTRANSFERASE 1A7; GLUCURONOSYLTRANSFERASE 1A8; GLUCURONOSYLTRANSFERASE 1A9; GROWTH HORMONE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENVIRONMENTAL EXPOSURE; FEMALE; FETUS; FETUS DEVELOPMENT; GROWTH HORMONE BLOOD LEVEL; HYPOPHYSIS ADRENAL SYSTEM; INTRAUTERINE GROWTH RETARDATION; MALE; NONHUMAN; PERINATAL PERIOD; PROTEIN EXPRESSION; RAT; STEROID METABOLISM; ANIMAL; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; HYPOPHYSIS; METABOLISM; NEWBORN; PREGNANCY; WISTAR RAT;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANIMALS, NEWBORN; CORTICOSTERONE; FEMALE; FETAL GROWTH RETARDATION; FETUS; GROWTH HORMONE; MALE; MATERNAL EXPOSURE; PITUITARY GLAND; PREGNANCY; RATS; RATS, WISTAR; TETRACHLORODIBENZODIOXIN;

EID: 84911004177     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-014-0257-3     Document Type: Article

References (57)

1. T.A. Gasiewicz, in 18.5 TCDD and other acnegenic materials, ed. by W.J. Hayes Jr., E.R. Laws. Handbook of pesticide toxicology, vol. 3, Classes of pesticides (Academic Press, San Diego, 1991), pp. 1217–1269
2. J.R. Olson, Metabolism and disposition of 2,3,7,8-tetrachlorodibenzo-p-dioxin in guinea pigs. Toxicol. Appl. Pharmacol. 85, 263–273 (1986)
3. J.L. Pirkle, W.H. Wolfe, D.G. Patterson, L.L. Needham, J.E. Michalek, J.C. Miner, M.R. Peterson, D.L. Phillips, Estimates of the half-life of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Vietnam veterans of Operation Ranch Hand. J. Toxicol. Environ. Health 27, 165–171 (1989)
4. B.D. Kerger, H.-W. Leung, P. Scott, D.J. Paustenbach, L.L. Needham, D.G. Patterson, P.M. Gerthoux Jr, P. Mocarelli, Age- and concentration-dependent elimination half-life of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Seveso children. Environ. Health Perspect. 114, 1596–1602 (2006)
5. A. Geusau, S. Schmaldienst, K. Derfler, O. Päpke, K. Abraham, Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: kinetics and trials to enhance elimination in two patients. Arch. Toxicol. 76, 316–325 (2002)
6. M. Van den Berg, J. De Jongh, H. Poiger, J.R. Olson, The toxicokinetics and metabolism of polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) and their relevance for toxicity. Crit. Rev. Toxicol. 24, 1–74 (1994)
7. C.H. Hurst, M.J. DeVito, R.W. Setzer, L.S. Birnbaum, Acute administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in pregnant Long Evans rats: association of measured tissue concentrations with developmental effects. Toxicol. Sci. 53, 411–420 (2000)
8. T. Tanida, K. Warita, K. Ishihara, S. Fukui, T. Mitsuhashi, T. Sugawara, Y. Tabuchi, T. Nanmori, W.M. Qi, T. Inamoto, T. Yokoyama, H. Kitagawa, N. Hoshi, Fetal and neonatal exposure to three typical environmental chemicals with different mechanisms of action: mixed exposure to phenol, phthalate, and dioxin cancels the effects of sole exposure on mouse midbrain dopaminergic nuclei. Toxicol. Lett. 189, 40–47 (2009)
9. L.E. Gray Jr, J.S. Ostby, In utero 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters reproductive morphology and function in female rat offspring. Toxicol. Appl. Pharmacol. 133, 285–294 (1995)
10. R.E. Peterson, H.M. Theobald, G.L. Kimmel, Developmental and reproductive toxicity of dioxins and related compounds: cross-species comparisons: cross-species comparisons. Crit. Rev. Toxicol. 23, 283–335 (1993)
11. M. Nishijo, J.I. Kuriwaki, E. Hori, K. Tawara, H. Nakagawa, H. Nishijo, Effects of maternal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin on fetal brain growth and motor and behavioral development in offspring rats. Toxicol. Lett. 173, 41–47 (2007)
12. T.A. Mably, R.W. Moore, R.E. Peterson, In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. Effects on androgenic status. Toxicol. Appl. Pharmacol. 114, 97–107 (1992)
13. D.L. Bjerke, R.E. Peterson, Reproductive toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in male rats: different effects of in utero versus lactational exposure. Toxicol. Appl. Pharmacol. 127, 241–249 (1994)
14. B.W. Seo, B.E. Powers, J.J. Widholm, S.L. Schantz, Radial arm maze performance in rats following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Neurotoxicol. Teratol. 22, 511–519 (2000)
15. J. Mutoh, J. Taketoh, K. Okamura, T. Kagawa, T. Ishida, Y. Ishii, H. Yamada, Fetal pituitary gonadotropin as an initial target of dioxin in its impairment of cholesterol transportation and steroidogenesis in rats. Endocrinology 147, 927–936 (2006)
16. J. Taketoh, J. Mutoh, T. Takeda, T. Ogishima, S. Takeda, Y. Ishii, T. Ishida, H. Yamada, Suppression of fetal testicular cytochrome P450 17 by maternal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: a mechanism involving an initial effect on gonadotropin synthesis in the pituitary. Life Sci. 80, 1259–1267 (2007)
17. T. Takeda, Y. Matsumoto, T. Koga, J. Mutoh, Y. Nishimura, T. Shimazoe, Y. Ishii, T. Ishida, H. Yamada, Maternal exposure to dioxin disrupts gonadotropin production in fetal rats and imprints defects in sexual behavior. J. Pharmacol. Exp. Ther. 329, 1091–1099 (2009)
18. T. Takeda, M. Fujii, J. Taura, Y. Ishii, H. Yamada, Dioxin silences gonadotropin expression in perinatal pups by inducing histone deacetylases: a new insight into the mechanism for the imprinting of sexual immaturity by dioxin. J. Biol. Chem. 287, 18440–18450 (2012)
19. T. Takeda, M. Fujii, Y. Hattori, M. Yamamoto, T. Shimazoe, Y. Ishii, M. Himeno, H. Yamada, Maternal exposure to dioxin imprints sexual immaturity of the pups through fixing the status of the reduced expression of hypothalamic gonadotropin-releasing hormone. Mol. Pharmacol. 85, 74–82 (2014)
20. K. De Jesus, X. Wang, J.L. Liu, A general IGF-I overexpression effectively rescued somatic growth and bone deficiency in mice caused by growth hormone receptor knockout. Growth Factors 27, 438–447 (2009)
21. K. Sjögren, Y.M. Bohlooly, B. Olsson, K. Coschigano, J. Törnell, S. Mohan, O.G.P. Isaksson, G. Baumann, J. Kopchhick, C. Ohlsson, Disproportional skeletal growth and markedly decreased bone mineral content in growth hormone receptor −/− mice. Biochem. Biophys. Res. Commun. 267, 603–608 (2000)
22. E. Li, D.H. Kim, M. Cai, S. Lee, Y. Kim, E. Lim, J.H. Ryu, T.G. Unterman, S. Park, Hippocampus-dependent spatial learning and memory are impaired in growth hormone-deficient spontaneous dwarf rats. Endocr. J. 58, 257–267 (2011)
23. R.G. Ahmed, Perinatal TCDD exposure alters developmental neuroendocrine system. Food Chem. Toxicol. 49, 1276–1284 (2011)
24. G. Cabello, C. Wrutniak, Thyroid hormone and growth: relationships with growth hormone effects and regulation. Reprod. Nutr. Dev. 29, 387–402 (1989)
25. B.-W. Seo, M.-H. Li, L.G. Hansen, R.W. Moore, R.J.Z. Peterson, S.L. Schantz, Effects of gestational and lactational exposure to coplanar polychlorinated biphenyl (PCB) congners or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on thyroid hormone concentrations in weanling rats. Toxicol. Lett. 78, 253–262 (1995)
26. N. Nishimura, J. Yonemoto, Y. Miyabara, M. Sato, C. Tohyama, Rat thyroid hyperplasia induced by gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Endocrinology 144, 2075–2083 (2003)
27. N. Nishimura, J. Yonemoto, H. Nishimura, S. Ikushiro, C. Tohyama, Disruption of thyroid hormone homeostasis at weaning of Holtzman rats by lactational but not in utero exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Sci. 85, 607–614 (2005)
28. H. Nogami, S. Hisano, Functional maturation of growth hormone cells in the anterior pituitary gland of the fetus. Growth hormon. IGF Res. 18, 379–388 (2008)
29. T.E. Porter, Regulation of pituitary somatotroph differentiation by hormones of peripheral endocrine glands. Domest. Anim. Endocrinol. 29, 52–62 (2005)
30. H. Nogami, K. Inoue, K. Kawamura, Involvement of glucocorticoid-induced factor(s) in the stimulation of growth hormone expression in the fetal rat pituitary gland in vitro. Endocrinology 138, 1810–1815 (1997)
31. H. Nogami, T. Tachibana, Dexamethasone induces advanced growth hormone expression in the fetal rat pituitary gland in vivo. Endocrinology 132, 517–523 (1993)
32. Y. Matsumoto, T. Ishida, T. Takeda, T. Koga, M. Fujii, Y. Ishii, Y. Fujimura, D. Miura, H. Wariishi, H. Yamada, Maternal exposure to dioxin reduces hypothalamic but not pituitary metabolome in fetal rats: a possible mechanism for a fetus-specific reduction in steroidogenesis. J. Toxicol. Sci. 35, 365–373 (2010)
33. J. Lépine, O. Bernard, M. Plante, B. Têtu, G. Pelletier, F. Labrie, A. Bélanger, C. Guillemette, Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium. J. Clin. Endocrinol. Metab. 89, 5222–5232 (2004)
34. K. Itäaho, P.I. Mackenzie, S. Ikushiro, J.O. Miners, M. Finel, The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases. Drug Metab. Dispos. 36, 2307–2315 (2008)
35. L. Kornel, S. Miyabo, Z. Saito, R.-W. Cha, F.-T. Wu, Corticosteroids in human blood. VIII. Cortisol metabolites in plasma of normotensive subjects and patients with essential hypertension. J. Clin. Endocrinol. Metab. 40, 949–958 (1975)
36. B.P. Schimmer, J.W. Funder, 42 ACTH, adrenal steroids, and pharmacology of the adrenal cortex, in Goodman and Gilman’s the pharmacological basis of therapeutics, 12th edn., ed. by L.L. Brunton, B.A. Chabner, B.C. Knollmann (McGraw-Hill Professional, New York, 2011), pp. 1209–1235
37. M.J. Nyirenda, R.S. Lindsay, C.J. Kenyon, A. Burchell, J.R. Seckl, Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J. Clin. Invest. 101, 2174–2181 (1998)
38. B.C. Bingham, C.S. Sheela Rani, A. Frazer, R. Strong, D.A. Morilak, Exogenous prenatal corticosterone exposure mimics the effects of prenatal stress on adult brain stress response systems and fear extinction behavior. Psychoneuroendocrinology 38, 2746–2757 (2013)
39. G. Mazziotti, A. Giustina, Glucocorticoids and the regulation of growth hormone secretion. Nat. Rev. Endocrinol. 9, 265–276 (2013)
40. A. Giustina, W.B. Wehrenberg, The role of glucocorticoids in the regulation of growth hormone secretion: mechanisms and clinical significance. Trends Endocrinol. Metab. 3, 306–311 (1992)
41. H. Vakili, Y. Jin, J.I. Nagy, P.A. Cattini, Transgenic mice expressing the human growth hormone gene provide a model system to study human growth hormone synthesis and secretion in non-tumor-derived pituitary cells: differential effects of dexamethasone and thyroid hormone. Mol. Cell. Endocrinol. 345, 48–57 (2011)
42. W.B. Wehrenberg, P.J. Bergman, L. Stagg, J. Ndon, A. Giustina, Glucocorticoid inhibition of growth in rats: partial reversal with somatostatin antibodies. Endocrinology 127, 2705–2708 (1990)
43. L. Li, Z.Q. Li, C.H. Deng, M.R. Ning, H.Q. Li, S.S. Bi, T.Y. Zhou, W. Lu, A mechanism-based pharmacokinetic/pharmacodynamic model for CYP3A1/2 induction by dexamethasone in rats. Acta Pharmacol. Sin. 33, 127–136 (2012)
44. N. Ejiri, K. Katayama, K. Doi, Induction of CYP3A1 by dexamethasone and pregnenolone-16alpha-carbonitrile in pregnant rat and fetal livers and placenta. Exp. Toxicol. Pathol. 54, 273–279 (2003)
45. T. Takeda, Y. Hattori, M. Fujii, J. Taura, Y. Ishii, H. Yamada, The gender-specific effect of maternal exposure to dioxin on fetal steroidogenesis in the adrenal gland. Fukuoka Acta Med. 104, 143–151 (2013)
46. M.J. Blake, L. Castro, J.S. Leeder, G.L. Kearns, Ontogeny of drug metabolizing enzymes in the neonate. Semin. Fetal Neonatal Med. 10, 123–138 (2005)
47. Z. Krozowski, K.X. Li, K. Koyama, R.E. Smith, V.R. Obeyesekere, A. Stein-Oakley, H. Sasano, C. Coulter, T. Cole, K.E. Sheppard, The type I and type II 11beta-hydroxysteroid dehydrogenase enzymes. J. Steroid Biochem. Mol. Biol. 69, 391–401 (1999)
48. M. Weinstock, Alterations induced by gestational stress in brain morphology and behaviour of the offspring. Prog. Neurobiol. 65, 427–451 (2001)
49. O.R. Vaughan, A.N. Sferruzzi-Perri, A.L. Fowden, Maternal corticosterone regulates nutrient allocation to fetal growth in mice. J. Physiol. 590, 5529–5540 (2012)
50. D.J. Auyeung, F.K. Kessler, J.K. Ritter, Mechanism of rat UDP-glucuronosyltransferase 1A6 induction by oltipraz: evidence for a contribution of the Aryl hydrocarbon receptor pathway. Mol. Pharmacol. 63, 119–127 (2003)
51. N. Nishimura, J. Yonemoto, Y. Miyabara, Y. Fujii-Kuriyama, C. Tohyama, Altered thyroxin and retinoid metabolic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin in aryl hydrocarbon receptor-null mice. Arch. Toxicol. 79, 260–267 (2004)
52. A. Fujisawa-Sehara, K. Sogawa, M. Yamane, Y. Fujii-Kuriyama, Characterization of xenobiotic responsive elements upstream from the drug-metabolizing cytochrome P-450c gene: a similarity to glucocorticoid regulatory elements. Nucleic Acids Res. 15, 4179–4191 (1987)
53. J. Wilson, Growth hormone modulation of liver drug metabolic enzyme activity in the rat. Specificity of the hormone effect. Proc. Soc. Exp. Biol. Med. 143, 978–985 (1973)
54. D.J. Waxman, C. O’Connor, Growth hormone regulation of sex-dependent liver gene expression. Mol. Endocrinol. 20, 2613–2629 (2006)
55. Y. Yamazoe, M. Shimada, N. Murayama, S. Kawano, R. Kato, The regulation by growth hormone of microsomal testosterone 6β-hydroxylase in male rat liver. J. Biochem. 100, 1095–1097 (1986)
56. S.K. Lu, S.M. Callahan, L.J. Brunner, Suppression of hepatic CYP3A1/2 and CYP2C11 by cyclosporine is not mediated by altering growth hormone levels. J. Pharmacol. Exp. Ther. 305, 331–337 (2003)
57. C. Lee, D.S. Riddick, Aryl hydrocarbon receptor-dependence of dioxin’s effects on constitutive mouse hepatic cytochromes P450 and growth hormone signaling components. Can. J. Physiol. Pharmacol. 90, 1354–1363 (2012)